Falcon Point Capital LLC Has $1.02 Million Holdings in Exactech, Inc. (EXAC)

Falcon Point Capital LLC lowered its position in shares of Exactech, Inc. (NASDAQ:EXAC) by 44.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 20,524 shares of the medical equipment provider’s stock after selling 16,328 shares during the quarter. Falcon Point Capital LLC owned 0.14% of Exactech worth $1,015,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently made changes to their positions in the business. The Manufacturers Life Insurance Company raised its position in Exactech by 3.2% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 9,323 shares of the medical equipment provider’s stock worth $278,000 after buying an additional 289 shares during the last quarter. Teachers Advisors LLC raised its position in Exactech by 2.7% during the 2nd quarter. Teachers Advisors LLC now owns 21,549 shares of the medical equipment provider’s stock worth $642,000 after buying an additional 568 shares during the last quarter. California Public Employees Retirement System raised its position in Exactech by 4.5% during the 2nd quarter. California Public Employees Retirement System now owns 23,100 shares of the medical equipment provider’s stock worth $688,000 after buying an additional 1,000 shares during the last quarter. Alliancebernstein L.P. raised its position in Exactech by 6.1% during the 2nd quarter. Alliancebernstein L.P. now owns 24,456 shares of the medical equipment provider’s stock worth $729,000 after buying an additional 1,400 shares during the last quarter. Finally, TIAA CREF Investment Management LLC raised its position in Exactech by 11.1% during the 2nd quarter. TIAA CREF Investment Management LLC now owns 34,438 shares of the medical equipment provider’s stock worth $1,026,000 after buying an additional 3,444 shares during the last quarter. Institutional investors own 61.22% of the company’s stock.

Exactech, Inc. (NASDAQ EXAC) opened at $49.25 on Wednesday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.09 and a current ratio of 4.08. Exactech, Inc. has a 12 month low of $23.75 and a 12 month high of $50.95. The firm has a market cap of $711.10, a price-to-earnings ratio of 40.74, a PEG ratio of 3.67 and a beta of 0.90.

A number of equities analysts have commented on the stock. Sidoti downgraded shares of Exactech from a “buy” rating to a “neutral” rating in a research report on Monday, October 23rd. BidaskClub downgraded shares of Exactech from a “sell” rating to a “strong sell” rating in a research report on Tuesday, January 30th. Robert W. Baird restated a “hold” rating and set a $49.00 price objective on shares of Exactech in a research report on Thursday, December 7th. Zacks Investment Research downgraded shares of Exactech from a “hold” rating to a “sell” rating in a research report on Wednesday, October 25th. Finally, Gabelli downgraded shares of Exactech from a “buy” rating to a “hold” rating in a research report on Tuesday, October 24th. Six research analysts have rated the stock with a hold rating, The stock presently has an average rating of “Hold” and an average price target of $49.00.

WARNING: This piece was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The correct version of this piece can be read at https://www.dispatchtribunal.com/2018/02/14/falcon-point-capital-llc-has-1-02-million-holdings-in-exactech-inc-exac.html.

Exactech Company Profile

Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines.

Want to see what other hedge funds are holding EXAC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exactech, Inc. (NASDAQ:EXAC).

Institutional Ownership by Quarter for Exactech (NASDAQ:EXAC)

Receive News & Ratings for Exactech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply